Cargando…

Elevated levels of serum CDCP1 in individuals recovering from severe COVID-19 disease

Background: COVID-19 survivors report residual lung abnormalities after discharge from the hospital. The aim of this study was to identify biomarkers in serum and induced sputum samples from patients after hospitalization for COVID-19. Methods: Patients admitted to hospitals in Spain with laboratory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanco, Jose-Ramon, Cobos-Ceballos, María-Jesús, Navarro, Francisco, Sanjoaquin, Isabel, Armiñanzas, Carlos, Bernal, Enrique, Buzon-Martin, Luis, Viribay, Miguel, Pérez-Martínez, Laura, Espejo-Pérez, Simona, Valencia, Borja, Guzman-Aguilar, Jesus, Ruiz-Cubillan, Juan-Jose, Alcalde, Consuelo, Gutierrez-Herrero, Fernando Gustavo, Olalla, Julian, Andres-Esteban, Eva-Maria, Jurado-Gamez, Bernabe, Ugedo, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908919/ https://www.ncbi.nlm.nih.gov/pubmed/35172279 http://dx.doi.org/10.18632/aging.203898

Ejemplares similares

Pulmonary long-term consequences of COVID-19 infections after hospital discharge
por: Blanco, Jose-Ramon, et al.
Publicado: (2021)

Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer
por: Yang, Lifang, et al.
Publicado: (2015)

Identification of CD318 (CDCP1) as novel prognostic marker in AML
por: Heitmann, Jonas S., et al.
Publicado: (2020)

Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer
por: Harrington, Brittney S., et al.
Publicado: (2020)

CDCP1 promotes compensatory renal growth by integrating Src and Met signaling
por: Kajiwara, Kentaro, et al.
Publicado: (2021)

Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer
por: Cuda, Tahleesa J., et al.
Publicado: (2021)

Cleaved CDCP1 marks the spot: a neoepitope for RAS-driven cancers
por: Donahue, Katelyn L., et al.
Publicado: (2022)

CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers
por: Turdo, Federica, et al.
Publicado: (2016)

Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma
por: Kryza, Thomas, et al.
Publicado: (2020)

Molecular mechanism by which CDCP1 promotes proneural-mesenchymal transformation in primary glioblastoma
por: Lin, Zhiying, et al.
Publicado: (2022)

AXL/CDCP1/SRC axis confers acquired resistance to osimertinib in lung cancer
por: Murakami, Yuichi, et al.
Publicado: (2022)

Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment
por: Wong, Sze‐Ching, et al.
Publicado: (2023)

Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer
por: Zhao, Jinlu, et al.
Publicado: (2022)

CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
por: Saponaro, Miriam, et al.
Publicado: (2023)

Metastatic prostate cancer‐derived extracellular vesicles facilitate osteoclastogenesis by transferring the CDCP1 protein
por: Urabe, Fumihiko, et al.
Publicado: (2023)

CDCP1 regulates retinal pigmented epithelial barrier integrity for the development of experimental autoimmune uveitis
por: Zhang, Lingjun, et al.
Publicado: (2022)

Effect of a Graduated Walking Program on the Severity of Obstructive Sleep Apnea Syndrome. A Randomized Clinical Trial
por: Jurado-García, Antonio, et al.
Publicado: (2020)

CUB Domain Containing Protein 1 (CDCP1) modulates adhesion and motility in colon cancer cells
por: Orchard-Webb, David J, et al.
Publicado: (2014)

CDCP1 Identifies a CD146 Negative Subset of Marrow Fibroblasts Involved with Cytokine Production
por: Iwata, Mineo, et al.
Publicado: (2014)

Structural Requirements for Cub Domain Containing Protein 1 (CDCP1) and Src Dependent Cell Transformation
por: Kollmorgen, Gwendlyn, et al.
Publicado: (2012)

Novel small molecule inhibiting CDCP1‐PKCδ pathway reduces tumor metastasis and proliferation
por: Nakashima, Katsuhiko, et al.
Publicado: (2017)

The emerging role of the MiR-1272-ADAM9-CDCP1 signaling pathway in the progression of glioma
por: Geng, Fei, et al.
Publicado: (2020)

Effects of Arginine Supplementation on Athletic Performance Based on Energy Metabolism: A Systematic Review and Meta-Analysis
por: Viribay, Aitor, et al.
Publicado: (2020)

Reply to La Marca et al. Comment on “Naranjo-Bonilla et al. Retinal and Choroidal Effects of Continuous Positive Airway Pressure as Treatment for Sleep Apnea: Results at 12 Months. Int. J. Environ. Res. Public Health 2022, 19, 12637”
por: Naranjo-Bonilla, Pedro, et al.
Publicado: (2023)

ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis
por: Chiu, Kuo-Liang, et al.
Publicado: (2015)

The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer
por: Forte, Luca, et al.
Publicado: (2018)

Increased Plasma Levels of the Co-stimulatory Proteins CDCP1 and SLAMF1 in Patients With Autoimmune Endocrine Diseases
por: Magnusson, Louise, et al.
Publicado: (2020)

Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers
por: Lim, Shion A., et al.
Publicado: (2022)

Author Correction: CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
por: Saponaro, Miriam, et al.
Publicado: (2023)

Ascites-derived CDCP1+ extracellular vesicles subcluster as a novel biomarker and therapeutic target for ovarian cancer
por: Kong, Lingnan, et al.
Publicado: (2023)

diaPASEF Proteomics and Feature Selection for the Description of Sputum Proteome Profiles in a Cohort of Different Subtypes of Lung Cancer Patients and Controls
por: Arenas-De Larriva, María del Sol, et al.
Publicado: (2022)

Retinal and Choroidal Effects of Continuous Positive Airway Pressure as Treatment for Sleep Apnea: Results at 12 Months
por: Naranjo-Bonilla, Pedro, et al.
Publicado: (2022)

Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese
por: Jia, Xi, et al.
Publicado: (2023)

Effectiveness of Digital Physiotherapy Practice Compared to Usual Care in Long COVID Patients: A Systematic Review
por: Estebanez-Pérez, María-José, et al.
Publicado: (2023)

Síndrome de la cabeza caída como primera manifestación de una esclerosis lateral amiotrófica
por: Herrero Antón, María José, et al.
Publicado: (2013)

Recovering Bioactive Compounds from Olive Oil Filter Cake by Advanced Extraction Techniques
por: Lozano-Sánchez, Jesús, et al.
Publicado: (2014)

KAI1 suppresses HIF-1α and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancer
por: Park, Jung-Jin, et al.
Publicado: (2012)

New crossroads for potential therapeutic intervention in cancer - intersections between CDCP1, EGFR family members and downstream signaling pathways
por: He, Yaowu, et al.
Publicado: (2016)

ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis
por: Chiu, Kuo-Liang, et al.
Publicado: (2017)

CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer
por: Nam, Yunha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mlkqpifdve2nb2fep6ir9c02bd